ZA907579B - Stabilized leukocyte-interferons - Google Patents

Stabilized leukocyte-interferons

Info

Publication number
ZA907579B
ZA907579B ZA907579A ZA907579A ZA907579B ZA 907579 B ZA907579 B ZA 907579B ZA 907579 A ZA907579 A ZA 907579A ZA 907579 A ZA907579 A ZA 907579A ZA 907579 B ZA907579 B ZA 907579B
Authority
ZA
South Africa
Prior art keywords
interferons
leukocyte
stabilized
stabilized leukocyte
Prior art date
Application number
ZA907579A
Other languages
English (en)
Inventor
Alberto Ferro
Ferro Alberto
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA907579B publication Critical patent/ZA907579B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA907579A 1989-09-28 1990-09-21 Stabilized leukocyte-interferons ZA907579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
ZA907579B true ZA907579B (en) 1991-06-26

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907579A ZA907579B (en) 1989-09-28 1990-09-21 Stabilized leukocyte-interferons

Country Status (26)

Country Link
EP (1) EP0420049B1 (cs)
JP (1) JPH03130232A (cs)
KR (1) KR910005886A (cs)
CN (1) CN1050503A (cs)
AR (1) AR244551A1 (cs)
AT (1) ATE92334T1 (cs)
AU (1) AU636653B2 (cs)
CA (1) CA2024046A1 (cs)
CZ (1) CZ277712B6 (cs)
DD (1) DD298054A5 (cs)
DE (1) DE59002183D1 (cs)
FI (1) FI904756A7 (cs)
HU (1) HU205555B (cs)
IE (1) IE903479A1 (cs)
IL (1) IL95769A0 (cs)
IS (1) IS3631A7 (cs)
MC (1) MC2149A1 (cs)
MX (1) MX22522A (cs)
MY (1) MY106615A (cs)
NO (1) NO904218L (cs)
NZ (1) NZ235153A (cs)
PH (1) PH27531A (cs)
PT (1) PT95454A (cs)
RU (1) RU2008017C1 (cs)
YU (1) YU184090A (cs)
ZA (1) ZA907579B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028020A1 (en) * 1993-05-18 1994-12-08 Bukh Meditec A/S A method for the preparation of interferons
AU2401197A (en) * 1996-05-09 1997-11-26 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
AU730020B2 (en) * 1997-05-09 2001-02-22 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
WO1999048535A1 (en) * 1998-03-26 1999-09-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
DE602005022895D1 (de) 2004-08-12 2010-09-23 Schering Corp Stabile pegylierte interferon-formulierung
DE102004048379A1 (de) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Federelement aus gesputterter Formgedächtnis-Legierung
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
ATE31023T1 (de) * 1983-04-28 1987-12-15 Armour Pharma Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
ES8705761A1 (es) * 1985-03-25 1987-05-16 Schering Corp Un metodo para preparar una formulacion liofilizada y estabilizada de gamma interferon
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
PT95454A (pt) 1991-05-22
FI904756A0 (fi) 1990-09-27
CN1050503A (zh) 1991-04-10
HU205555B (en) 1992-05-28
IE903479A1 (en) 1991-04-10
MY106615A (en) 1995-06-30
YU184090A (sh) 1992-09-07
RU2008017C1 (ru) 1994-02-28
NZ235153A (en) 1993-03-26
AR244551A1 (es) 1993-11-30
DD298054A5 (de) 1992-02-06
AU6309890A (en) 1991-04-11
NO904218D0 (no) 1990-09-27
JPH03130232A (ja) 1991-06-04
EP0420049A1 (de) 1991-04-03
CS432890A3 (en) 1992-12-16
KR910005886A (ko) 1991-04-27
HUT56284A (en) 1991-08-28
DE59002183D1 (de) 1993-09-09
ATE92334T1 (de) 1993-08-15
MC2149A1 (fr) 1992-03-10
AU636653B2 (en) 1993-05-06
MX22522A (es) 1993-10-01
HU906021D0 (en) 1991-03-28
FI904756A7 (fi) 1991-03-29
NO904218L (no) 1991-04-02
EP0420049B1 (de) 1993-08-04
IS3631A7 (is) 1991-03-29
PH27531A (en) 1993-08-18
CZ277712B6 (en) 1993-03-17
IL95769A0 (en) 1991-06-30
CA2024046A1 (en) 1991-03-29

Similar Documents

Publication Publication Date Title
DE69030767D1 (en) Defibrillationselektrode
AU108277S (en) Hedge-shears
DE68927004D1 (en) Multiplex-synchron/asynchron-datenbus
DE4090310D2 (en) Teleskopkrone
DE3991623D2 (en) Frequenzueberwachungsanordnung
CS9005442A2 (en) Symmetrizer
DE4090235D2 (de) Hauptabsperrventil
CS490790A3 (en) Chaff-cutter
ZA907579B (en) Stabilized leukocyte-interferons
DE4090110D2 (en) Rotationskolbenverbrennungskraftmaschine
DE59010417D1 (en) Cyclische polyiminoether
DE4092115D2 (en) Sanitaere mischbatterie
DE4091364D2 (en) Thermosaeulen-strahlungsdetektor
DE4091275D2 (en) Steppdecke
BG49771A1 (en) Electric- bow evaparator
DE4090763D2 (en) Abfallsammler
DE69027068D1 (en) Spiropyranverbindungen
DE69030237D1 (en) Kalispenderzubereitung
DE3991686D2 (de) Schmuckblende
DE4091102D2 (de) Spundlochverschluss
DE3991687D2 (de) Dufttresor
EP0419411A3 (en) Additional alkanophenones
DE69024223D1 (en) Fluidmaschine
DE3991146D2 (en) Schraubverschluss
CA64838S (en) Automibile